Product Images Irinotecan Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Irinotecan Hydrochloride NDC 16714-027 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Irinotecan-Carton-Labeling-100mg - irinotecan 100mg 5ml carton

Irinotecan-Carton-Labeling-100mg - irinotecan 100mg 5ml carton

This is information about Sterie, an aqueous solution used for intravenous purposes. The solution must be diluted before use and stored between 20-25°C. It is cautioned to protect the solution from light and freezing, and if contents are damaged or leaking, the entire package must be incinerated. The dosage and use instructions are not available in this text. The package contains Irinotecan Hydrochloride injection, which is a cytotoxic agent that comes in a 5mL single-dose vial. The manufacturer of the product is Northstar Rx LLC in Tennessee and is produced by Gland Pharma Ltd in India.*

Irinotecan-Container-Label-100mg - irinotecan 100mg 5ml vial

Irinotecan-Container-Label-100mg - irinotecan 100mg 5ml vial

The text describes a medication called irinotecan hydrochloride, which is available in a 100mg/5ml single-dose vial for intravenous use. The medication is a cytotoxic agent that must be diluted before administration. It should be stored at temperatures between 20-25°C and protected from freezing and light. The information on dosage and usage are described in the accompanying prescribing information. The medication is manufactured by Gland Pharma Ltd in India and distributed by Northstar Rx LLC in Memphis, TN. The lot number and expiration date for the medication are not available.*

Irinotecan-Carton-Labeling-40mg - irinotecan 40mg 2ml carton

Irinotecan-Carton-Labeling-40mg - irinotecan 40mg 2ml carton

This is a description for a medication called Irinotecan Hydrochloride Injection, USP. It is a cytotoxic agent and should only be used intravenously. The medication must be diluted before use and caution should be taken during its use. The packaging must be incinerated if contents are damaged or leaking. Dosage and usage guidance are not provided and must be followed through accompanying prescribed information. The medication must be stored at a controlled room temperature between 20° to 25°C (68° to 77°F), protected from light and freezing, and stored in its original carton. The medication is manufactured in India and distributed by Northstar Rx LLC.*

Irinotecan-Container-Label-40mg - irinotecan 40mg 2ml vial

Irinotecan-Container-Label-40mg - irinotecan 40mg 2ml vial

irinotecan spl figure 1

irinotecan spl figure 1

irinotecan spl figure 2

irinotecan spl figure 2

irinotecan-spl-figure-3 - irinotecan spl figure 3

irinotecan-spl-figure-3 - irinotecan spl figure 3

irinotecan-spl-figure-4 - irinotecan spl figure 4

irinotecan-spl-figure-4 - irinotecan spl figure 4

The text is providing information about the probability of a certain event and the medical treatment with Innotecan and 5-FU. It also includes some numerical values such as N, median follow-up, and median in months. However, without more context, it is not clear what event or medical condition is being referred to.*

irinotecan-spl-structure - irinotecan spl structure

irinotecan-spl-structure - irinotecan spl structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.